SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-077001
Filing Date
2021-06-04
Accepted
2021-06-04 16:06:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2118805d2_defa14a.htm DEFA14A 105652
2 GRAPHIC tm2118805d1_ex99-1img01.jpg GRAPHIC 41885
  Complete submission text file 0001104659-21-077001.txt   164782
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33958 | Film No.: 21996496
SIC: 2834 Pharmaceutical Preparations